NAV on (15 Oct 2026 )
₹36.97 ▼
(-0.18%)
Fund Size
₹1511.49 Crores
1Y Returns
3.38 %
The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Launch Date
December 4, 2015
Fund Manager
Mr. Rajat Srivastava
Initial Price
10
AUM Fund
1511.49 Cr
Min investment
Rs 5000
Expense Ratio
1.07%
Daily - Rs. 150/- and in multiples of Re. 1/- thereafter. Minimum 12 installments.Monthly - Rs. 150/- and multiple of Re. 1/- thereafter. Minimum 12 installments.Monthly - Rs. 1000/- and multiple of Re. 1/- thereafter. Minimum 6 installments.Quarterly - Rs. 1000/- and multiple of Re. 1/- thereafter. Minimum 6 installments.Quarterly - Rs. 1500/- and multiple of Re. 1/- thereafter. Minimum 4 installments.
0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.
1 Month
-4.95%
6 Months
+7.16%
1 Year
+3.38%
2 Years (CAGR)
+1.10%
3 Years (CAGR)
+17.31%
5 Years (CAGR)
+13.31%
| Equity / Mid Cap funds | 1Y | 3Y | Fund Size (Cr) |
|---|---|---|---|
| 20.64% | 0.00% | ₹825.14 | |
| 20.63% | 0.00% | ₹825.14 | |
| 20.52% | 111.29% | ₹3501.37 | |
| 20.52% | 111.29% | ₹3501.37 | |
| 19.18% | 103.90% | ₹3501.37 |
Q: What is the current NAV of Tata India Pharma & HealthCare Fund - Direct Plan - Growth?
A: The latest NAV of Tata India Pharma & HealthCare Fund - Direct Plan - Growth is ₹ 36.97 as on 15 Oct 2026.
Q: What type of mutual fund is Tata India Pharma & HealthCare Fund - Direct Plan - Growth?
A: Tata India Pharma & HealthCare Fund - Direct Plan - Growth is a 'Equity - Pharma' type mutual fund managed by 'Tata Asset Management Ltd.'.
Q: What is the expense ratio of Tata India Pharma & HealthCare Fund - Direct Plan - Growth?
A: The expense ratio of Tata India Pharma & HealthCare Fund - Direct Plan - Growth is 1.07%, which impacts overall returns.
Q: Who manages Tata India Pharma & HealthCare Fund - Direct Plan - Growth?
A: Tata India Pharma & HealthCare Fund - Direct Plan - Growth is managed by Mr. Rajat Srivastava, who oversees investment strategy and portfolio decisions.
Q: Is Tata India Pharma & HealthCare Fund - Direct Plan - Growth a good investment?
A: Tata India Pharma & HealthCare Fund - Direct Plan - Growth may be suitable depending on your financial goals, risk appetite, and investment horizon. Always evaluate fund performance and consult a financial advisor.
Q: What is the exit load of Tata India Pharma & HealthCare Fund - Direct Plan - Growth?
A: The exit load of Tata India Pharma & HealthCare Fund - Direct Plan - Growth is 0.25% of NAV if redeemed/switched out before 30 days from the date of allotment., applicable if redeemed within the specified period.
Q: How is Tata India Pharma & HealthCare Fund - Direct Plan - Growth taxed?
A: Taxation depends on the fund type (equity/debt) and holding period as per Indian tax laws.
